Related Experiment Video
Updated: Dec 27, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis
Alexandra Desnoyers1, Carlos González1,2,3,4,5, Pedro Pérez-Segura2
1Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, The University of Toronto, Toronto, ON, Canada.
High ανβ6 integrin expression in solid tumors is linked to worse overall survival (OS). This finding highlights ανβ6 integrin as a potential prognostic marker and therapeutic target in various cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Integrins are cell surface receptors mediating extracellular matrix interactions and intracellular signaling.
- Integrins, particularly ανβ6 integrin, are implicated in cancer progression, promoting migration, invasion, metastasis, and survival.
- ανβ6 integrin is frequently overexpressed in various solid tumors.
Purpose of the Study:
- To evaluate the prognostic impact of ανβ6 integrin protein expression on overall survival (OS) in patients with solid tumors.
- To synthesize existing evidence through a meta-analysis to determine the association between ανβ6 integrin expression and patient outcomes.
Main Methods:
- Systematic literature search of electronic databases for studies on ανβ6 integrin and OS.
- Meta-analysis of hazard ratios (HRs) using inverse variance and random effects models.
- Subgroup analyses based on tumor site, stage, immunohistochemistry (IHC) antibody, and HR extraction method; meta-regression to explore clinical variable influence.
Main Results:
- Seventeen studies including 5795 patients were analyzed.
- High ανβ6 integrin expression correlated with significantly worse OS (HR 1.65, 95% CI 1.32-2.06).
- Adverse outcomes were consistent across tumor sites, with strongest association in gastric cancer and weakest in head and neck cancer; no significant differences based on stage, IHC antibody, or analysis method.
Conclusions:
- Elevated ανβ6 integrin expression is associated with poorer survival outcomes in multiple solid tumors.
- ανβ6 integrin may serve as a valuable prognostic biomarker in oncology.
- Further prospective studies are needed to confirm the prognostic significance of ανβ6 integrin and explore its therapeutic potential.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Cancer Survival Analysis
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...